Overview
Patierno's current translational research interests are focused on the genomics molecular biology of cancer disparities, cancer biology, molecular pharmacology and targeted experimental therapeutics to control prostate, breast and lung tumor aggressiveness. He is an internationally recognized expert in cancer control, cancer causation and molecular carcinogenesis, which includes a broad spectrum of laboratory and population level research. Patierno is also actively engaged in cancer health disparities and healthcare delivery research focused on patient navigation, survivorship, community-based interventions, mHealth, implementation sciences, cancer care economics, and policy.
Current Appointments & Affiliations
Charles D. Watts Distinguished Professor of Medicine
·
2023 - Present
Medicine, Medical Oncology,
Medicine
Professor of Medicine
·
2013 - Present
Medicine, Medical Oncology,
Medicine
Professor in Family Medicine and Community Health
·
2013 - Present
Family Medicine and Community Health,
Clinical Science Departments
Professor of Pharmacology and Cancer Biology
·
2013 - Present
Pharmacology & Cancer Biology,
Basic Science Departments
Member of the Duke Cancer Institute
·
2012 - Present
Duke Cancer Institute,
Institutes and Centers
Core Faculty Member, Duke-Margolis Institute for Health Policy
·
2024 - Present
Duke-Margolis Institute for Health Policy,
University Institutes and Centers
Recent Publications
Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Other · November 24, 2025 <div>Abstract<p>Triple-negative breast cancers (TNBC) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early-stage localized TNBC, the rate of distant recurrence remains hi ... Full text CiteSupplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Other · November 24, 2025 <p>Supplementary Video 4</p> ... Full text CiteSupplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Other · November 24, 2025 <p>Supplementary Video 2</p> ... Full text CiteRecent Grants
2/3 CTSA K12 Program at Duke University
ResearchMentor · Awarded by National Institutes of Health · 2025 - 2030Duke University Program in Environmental Health
Inst. Training Prgm or CMEMentor · Awarded by National Institute of Environmental Health Sciences · 2019 - 2029Elucidating the role of transcriptomics in colorectal cancer disparities across diverse populations
ResearchCo Investigator · Awarded by Cedars Sinai Medical Center · 2024 - 2029View All Grants
Education, Training & Certifications
University of Texas Medical School, Houston ·
1985
Ph.D.
University of Connecticut ·
1981
B.S.